Global Artificial Heart Market 2019-2023
SKU ID : TNV-14252570 | Publishing Date : 14-May-2019 | No. of pages : 117
Detailed TOC of Global Artificial Heart Market 2019-2023
PART 01: EXECUTIVE SUMMARYPART 02: SCOPE OF THE REPORT
• 2.1 Preface
• 2.2 Preface
• 2.3 Currency conversion rates for US$
PART 03: MARKET LANDSCAPE
• Market ecosystem
• Market characteristics
• Market segmentation analysis
PART 04: MARKET SIZING
• Market definition
• Market sizing 2018
• Market size and forecast 2018-2023
PART 05: FIVE FORCES ANALYSIS
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition
PART 06: MARKET SEGMENTATION BY PRODUCT
• Market segmentation by product
• Comparison by product
• VAD - Market size and forecast 2018-2023
• TAH - Market size and forecast 2018-2023
• Market opportunity by product
PART 07: CUSTOMER LANDSCAPE
PART 08: GEOGRAPHIC LANDSCAPE
• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2018-2023
• Europe - Market size and forecast 2018-2023
• Asia - Market size and forecast 2018-2023
• ROW - Market size and forecast 2018-2023
• Key leading countries
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Clinical trials for the development of TAHs
• Focus on development of non-blood-contacting VADs
• Strategic acquisitions
PART 12: VENDOR LANDSCAPE
• Overview
• Landscape disruption
PART 13: VENDOR ANALYSIS
• Vendors covered
• Vendor classification
• Market positioning of vendors
• Abbott
• Abiomed Inc.
• Medtronic
• ReliantHeart Inc.
• SynCardia Systems LLC
PART 14: APPENDIX
• Research methodology
• List of abbreviations
• Definition of market positioning of vendors
PART 15: EXPLORE TECHNAVIO
Exhibit 01: Global medical devices market
Exhibit 02: Segments of global medical devices market
Exhibit 03: Market characteristics
Exhibit 04: Market segments
Exhibit 05: Market definition - Inclusions and exclusions checklist
Exhibit 06: Market size 2018
Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions)
Exhibit 08: Global market: Year-over-year growth 2019-2023 (%)
Exhibit 09: Five forces analysis 2018
Exhibit 10: Five forces analysis 2023
Exhibit 11: Bargaining power of buyers
Exhibit 12: Bargaining power of suppliers
Exhibit 13: Threat of new entrants
Exhibit 14: Threat of substitutes
Exhibit 15: Threat of rivalry
Exhibit 16: Market condition - Five forces 2018
Exhibit 17: Product - Market share 2018-2023 (%)
Exhibit 18: Comparison by product
Exhibit 19: VAD - Market size and forecast 2018-2023 ($ millions)
Exhibit 20: VAD - Year-over-year growth 2019-2023 (%)
Exhibit 21: TAH - Market size and forecast 2018-2023 ($ millions)
Exhibit 22: TAH - Year-over-year growth 2019-2023 (%)
Exhibit 23: Market opportunity by product
Exhibit 24: Customer landscape
Exhibit 25: Market share by geography 2018-2023 (%)
Exhibit 26: Geographic comparison
Exhibit 27: North America - Market size and forecast 2018-2023 ($ millions)
Exhibit 28: North America - Year-over-year growth 2019-2023 (%)
Exhibit 29: Europe - Market size and forecast 2018-2023 ($ millions)
Exhibit 30: Europe - Year-over-year growth 2019-2023 (%)
Exhibit 31: Asia - Market size and forecast 2018-2023 ($ millions)
Exhibit 32: Asia - Year-over-year growth 2019-2023 (%)
Exhibit 33: ROW - Market size and forecast 2018-2023 ($ millions)
Exhibit 34: ROW - Year-over-year growth 2019-2023 (%)
Exhibit 35: Key leading countries
Exhibit 36: Market opportunity
Exhibit 37: Impact of drivers and challenges
Exhibit 38: Vendor landscape
Exhibit 39: Landscape disruption
Exhibit 40: Vendors covered
Exhibit 41: Vendor classification
Exhibit 42: Market positioning of vendors
Exhibit 43: Abbott - Vendor overview
Exhibit 44: Abbott - Business segments
Exhibit 45: Abbott - Organizational developments
Exhibit 46: Abbott - Geographic focus
Exhibit 47: Abbott - Segment focus
Exhibit 48: Abbott - Key offerings
Exhibit 49: Abbott - Key customers
Exhibit 50: Abiomed Inc. - Vendor overview
Exhibit 51: Abiomed Inc. - Product segments
Exhibit 52: Abiomed Inc. - Organizational developments
Exhibit 53: Abiomed Inc. - Segment focus
Exhibit 54: Abiomed Inc. - Key offerings
Exhibit 55: Abiomed Inc. - Key customers
Exhibit 56: Medtronic - Vendor overview
Exhibit 57: Medtronic - Business segments
Exhibit 58: Medtronic - Organizational developments
Exhibit 59: Medtronic - Geographic focus
Exhibit 60: Medtronic - Segment focus
Exhibit 61: Medtronic - Key offerings
Exhibit 62: Medtronic - Key customers
Exhibit 63: ReliantHeart Inc. - Vendor overview
Exhibit 64: ReliantHeart Inc. - Product segments
Exhibit 65: ReliantHeart Inc. - Organizational developments
Exhibit 66: ReliantHeart Inc. - Key offerings
Exhibit 67: ReliantHeart Inc. - Key customers
Exhibit 68: SynCardia Systems LLC - Vendor overview
Exhibit 69: SynCardia Systems LLC - Product segments
Exhibit 70: SynCardia Systems LLC - Organizational developments
Exhibit 71: SynCardia Systems LLC - Key offerings
Exhibit 72: SynCardia Systems LLC - Key customers
Exhibit 73: Validation techniques employed for market sizing
Exhibit 74: Definition of market positioning of vendors
Keyplayers in Global Artificial Heart Market 2019-2023
AbbottAbiomed Inc.
Medtronic
ReliantHeart Inc.
SynCardia Systems LLC